Adham Khalil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Adham Khalil has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Clifford R. Weiss
Johns Hopkins University School of Medicine
9 shared publications Christopher R. Bailey
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, United States
4 shared publications- Prateek C. Gowda
The Johns Hopkins University School of Medicine, Baltimore, MD, United States of America
4 shared publications - Tushar Garg
Department of Radiology and Radiological Sciences, Division of Neuroradiology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
4 shared publications Anna J. Gong
Johns Hopkins University School of Medicine, Baltimore, Maryland
2 shared publications- Anna J. Gong
Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland
2 shared publications
Latest Publications
- Open Access
- 20 November 2025
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 15, 43
Improving cone-beam computed tomography image quality for transarterial therapy of liver malignancies: Evaluation of a motion correction algorithm with and without automated bone removal
Objectives: The objectives of the study are to compare the effect on image quality of a motion artifact correction algorithm (CAVAREC) alone versus in combination with an automated bone removal algorithm (ZIBOS) for motion-degraded intraprocedural liver cone-beam computed tomography (CBCT) images. Material and Methods: In this retrospective, two-center, Institutional Review Board (IRB)-approved study, 48 CBCTs from 41 patients were included. Inclusion criteria were (a) age ≥18; (b) liver CBCT with contrast injected at the main, right, or left hepatic artery; and (c) CBCT motion-degraded. Exclusion criteria were (a) no visible tumor and (b) CBCT not capturing the entire liver. The mean (standard deviation [SD]) age was 64 (7) years, 81% male. 65% had hepatocellular carcinoma and 35% metastatic cancer. 69% CBCTs were from transarterial radioembolization (TARE) mapping, 25% transarterial chemoembolization, and 6% TARE treatment. Mean (SD) maximum tumor diameter was 4.6 (2.7) cm. CBCT images were processed with CAVAREC (prototype, Siemens Healthineers AG, Forchheim, Germany) and CAVAREC + ZIBOS (work in progress, Comprehenso, Hannover, Germany). Using CoroEval, sharpness for two segmental arteries per case was obtained quantitatively. Three blinded interventional radiologists independently evaluated overall image quality on a 0–100 scale and large vessels, small vessels, vessel sharpness, tumor feeders, tumor blush, and streak artifacts on a −50 to +50 scale relative to uncorrected images. Results were analyzed with paired t- tests and Wilcoxon signed-rank tests, adjusting P -values with the Benjamini–Hochberg procedure. Results: On quantitative assessment, mean (SD) sharpness for uncorrected, CAVAREC, and CAVAREC + ZIBOS (C+Z) images was 0.281 (0.04), 0.287 (0.04), and 0.284 (0.04), respectively, P = 0.02 for uncorrected versus CAVAREC and P > 0.05 for other comparisons. On qualitative assessment, mean (SD) overall quality for uncorrected, CAVAREC, and C+Z images was 45 (14), 53 (16), and 53 (17), respectively, P < 0.001 for both uncorrected versus CAVAREC and uncorrected versus C+Z and P = 0.06 for CAVAREC versus C+Z. The mean preference for both CAVAREC and C+Z compared to uncorrected images for all parameters ranged from +4.3 to +9.5, P < 0.001, except tumor blush which was +1.6 for CAVAREC and +0.9 for C+Z, P > 0.05. CAVAREC versus C+Z was not significant for any parameter. Conclusion: Motion artifact correction of liver CBCT images using CAVAREC improves image quality significantly. According to observer studies, integrating the automated bone segmentation algorithm ZIBOS with CAVAREC does not degrade image quality.
- 20 November 2025
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 15, 43
Open AccessImproving cone-beam computed tomography image quality for transarterial therapy of liver malignancies: Evaluation of a motion correction algorithm with and without automated bone removal
Objectives: The objectives of the study are to compare the effect on image quality of a motion artifact correction algorithm (CAVAREC) alone versus in combination with an automated bone removal algorithm (ZIBOS) for motion-degraded intraprocedural liver cone-beam computed tomography (CBCT) images. Material and Methods: In this retrospective, two-center, Institutional Review Board (IRB)-approved study, 48 CBCTs from 41 patients were included. Inclusion criteria were (a) age ≥18; (b) liver CBCT with contrast injected at the main, right, or left hepatic artery; and (c) CBCT motion-degraded. Exclusion criteria were (a) no visible tumor and (b) CBCT not capturing the entire liver. The mean (standard deviation [SD]) age was 64 (7) years, 81% male. 65% had hepatocellular carcinoma and 35% metastatic cancer. 69% CBCTs were from transarterial radioembolization (TARE) mapping, 25% transarterial chemoembolization, and 6% TARE treatment. Mean (SD) maximum tumor diameter was 4.6 (2.7) cm. CBCT images were processed with CAVAREC (prototype, Siemens Healthineers AG, Forchheim, Germany) and CAVAREC + ZIBOS (work in progress, Comprehenso, Hannover, Germany). Using CoroEval, sharpness for two segmental arteries per case was obtained quantitatively. Three blinded interventional radiologists independently evaluated overall image quality on a 0–100 scale and large vessels, small vessels, vessel sharpness, tumor feeders, tumor blush, and streak artifacts on a −50 to +50 scale relative to uncorrected images. Results were analyzed with paired t- tests and Wilcoxon signed-rank tests, adjusting P -values with the Benjamini–Hochberg procedure. Results: On quantitative assessment, mean (SD) sharpness for uncorrected, CAVAREC, and CAVAREC + ZIBOS (C+Z) images was 0.281 (0.04), 0.287 (0.04), and 0.284 (0.04), respectively, P = 0.02 for uncorrected versus CAVAREC and P > 0.05 for other comparisons. On qualitative assessment, mean (SD) overall quality for uncorrected, CAVAREC, and C+Z images was 45 (14), 53 (16), and 53 (17), respectively, P < 0.001 for both uncorrected versus CAVAREC and uncorrected versus C+Z and P = 0.06 for CAVAREC versus C+Z. The mean preference for both CAVAREC and C+Z compared to uncorrected images for all parameters ranged from +4.3 to +9.5, P < 0.001, except tumor blush which was +1.6 for CAVAREC and +0.9 for C+Z, P > 0.05. CAVAREC versus C+Z was not significant for any parameter. Conclusion: Motion artifact correction of liver CBCT images using CAVAREC improves image quality significantly. According to observer studies, integrating the automated bone segmentation algorithm ZIBOS with CAVAREC does not degrade image quality.
- Open Access
- 25 September 2025
- Published by Elsevier in Obesity Pillars
- Vol. 16, 100211
Establishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience
- 25 September 2025
- Published by Elsevier in Obesity Pillars
- Vol. 16, 100211
Open AccessEstablishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience
- 24 December 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (4) , 601.e1-601.e9
Clinical and Imaging Outcomes of Doxycycline Exchange Sclerotherapy for Lymphatic Malformations
- 24 December 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (4) , 601.e1-601.e9
Clinical and Imaging Outcomes of Doxycycline Exchange Sclerotherapy for Lymphatic Malformations
- 24 June 2023
- Published by Elsevier in Clinical Imaging
- Vol. 101, 183-189
Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia
- 24 June 2023
- Published by Elsevier in Clinical Imaging
- Vol. 101, 183-189
Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia
- 15 May 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (9) , 1609-1617.e2
Intraoperative Neuromonitoring during Peripheral Arteriovenous Malformation Embolization
- 15 May 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (9) , 1609-1617.e2
Intraoperative Neuromonitoring during Peripheral Arteriovenous Malformation Embolization
- 1 March 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (3) , e212403
Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes
Among the abdominal CT–based body composition measurements typically available before liver transplant, sarcopenia was the only binary factor significantly associated with posttransplant outcomes. Background Pre–liver transplant (LT) sarcopenia is associated with poor survival. Methods exist for measuring body composition with use of CT scans; however, it is unclear which components best pre...
- 1 March 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (3) , e212403
Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes
Among the abdominal CT–based body composition measurements typically available before liver transplant, sarcopenia was the only binary factor significantly associated with posttransplant outcomes. Background Pre–liver transplant (LT) sarcopenia is associated with poor survival. Methods exist for measuring body composition with use of CT scans; however, it is unclear which components best pre...
- 7 February 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (5) , 840-848.e5
Responsiveness of the Patient-Reported Outcome Measure for Vascular Malformation Questionnaire in Patients with Low-Flow Vascular Malformations
- 7 February 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (5) , 840-848.e5
Responsiveness of the Patient-Reported Outcome Measure for Vascular Malformation Questionnaire in Patients with Low-Flow Vascular Malformations
- 24 September 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (1) , 4-10.e3
Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies
- 24 September 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (1) , 4-10.e3
Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies
- 16 July 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (11) , 1349-1354
Percutaneous Cryoablation for Symptomatic Peripheral Congenital Hemangioma
- 16 July 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (11) , 1349-1354
Percutaneous Cryoablation for Symptomatic Peripheral Congenital Hemangioma
- 1 January 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (1) , 92-93.e1
Percutaneous Sclerotherapy of a Large Trans-Spatial Oropharyngeal Venous Malformation Using Multimodality Guidance
- 1 January 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (1) , 92-93.e1
Percutaneous Sclerotherapy of a Large Trans-Spatial Oropharyngeal Venous Malformation Using Multimodality Guidance